USE OF COMBINATION OF IRINOTECAN, IMMUNE CHECKPOINT INHIBITOR, AND 5-FU IN PREPARATION OF DRUGS FOR TREATING TUMOR DISEASES

Provided in the present application is use of a combination of Irinotecan, an immune checkpoint inhibitor, and 5-FU in preparation of drugs for preventing or treating tumor diseases. Specifically, provided in the present application is use of a combination of Irinotecan or a pharmaceutically accepta...

Full description

Saved in:
Bibliographic Details
Main Authors WANG, Fuji, CAO, Yong
Format Patent
LanguageChinese
English
French
Published 30.04.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided in the present application is use of a combination of Irinotecan, an immune checkpoint inhibitor, and 5-FU in preparation of drugs for preventing or treating tumor diseases. Specifically, provided in the present application is use of a combination of Irinotecan or a pharmaceutically acceptable salt thereof, a PD-L1 antibody or antigen binding segment, and 5-FU in preparation of drugs for preventing or treating tumor diseases. La présente invention concerne l'utilisation d'une association d'irinotécan, d'un inhibiteur de point de contrôle immunitaire et de 5-FU dans la préparation de médicaments destinés à la prévention ou au traitement de maladies tumorales. Plus précisément, la présente invention concerne l'utilisation d'une association d'irinotécan ou d'un sel pharmaceutiquement acceptable correspondant, d'un anticorps anti-PD-L1 ou d'un segment de liaison à l'antigène, et de 5-FU dans la préparation de médicaments destinés à la prévention ou au traitement de maladies tumorales. 本申请提供了伊立替康联合免疫检查点抑制
Bibliography:Application Number: WO2019CN113009